While these factors may have a genetic basis (e.g., tau and cognitive decline [21, 53], proteostasis and age of onset [20, 29]), our data indicate that non-cell autonomous spread of mHTT is a novel modifier of HD disease progression. Here, MAPT is linked to Huntington disease.